Shaanxi Kelong New Material Technology
920098
Anhui Wanyi Science And Technology
688600
Qingdao Kutesmart Co.,Ltd.
300840
Xinling Electrical
301388
KAISA JiaYun Technology Inc.
300242
CN Stock MarketDetailed Quotes
002020 Zhejiang Jingxin Pharmaceutical
- 12.86
- +0.25+1.98%
Market Closed Dec 6 15:00 CST
11.07BMarket Cap15.35P/E (TTM)
12.89High12.58Low130.15KlotVolume12.61Open12.61Pre Close166.15MTurnover1.80%Turnover Ratio17.89P/E (Static)861.03MShares13.9952wk High1.90P/B9.31BFloat Cap7.9852wk Low13.87Limit Up723.97MShs Float15.86Historical High11.35Limit Down2.46%Amplitude-1.38Historical Low0.30Dividend TTM12.77Avg Price54.27KlotAsk2.33%Div YieldTTM100Lot Size71.26KlotBid
Zhejiang Jingxin Pharmaceutical News
Jingxin Pharmaceutical: Announcement on the inclusion of didacinib capsules in the national medical insurance catalogue
Jingxin Pharmaceutical: Report for the third quarter of 2024
Jingxin Pharmaceutical: Announcement on cancellation of majority shareholders\' share pledges
Jingxin Pharmaceutical: Ping An Securities Co., Ltd.\'s inspection opinion on the listing and circulation of Jingxin Pharmaceutical\'s non-public restricted shares
Jingxin Pharmaceutical: An indicative announcement on the listing and circulation of restricted non-public shares in 2020
Zhejiang Jingxin Pharmaceutical: Investor relations management information of Zhejiang Jingxin Pharmaceutical as of August 16, 2024.
Zhejiang Jingxin Pharmaceutical: Summary table of non-operating funds utilization and other related funds flow for the first half of the year.
Zhejiang Jingxin Pharmaceutical: Announcement regarding increase in entrusted wealth management limit of idle proprietary funds.
Zhejiang Jingxin Pharmaceutical: Special report on the collection and use of funds for the first half of 2024.
Zhejiang Jingxin Pharmaceutical: Announcement of the resolution of the Supervisory Board on the semi-annual report.
Zhejiang Jingxin Pharmaceutical: Announcement of Board of Directors' resolution for semi-annual report.
Zhejiang Jingxin Pharmaceutical: Half-year report for the year 2024.
Zhejiang Jingxin Pharmaceutical: Financial Report for the first half of 2024.
Zhejiang Jingxin Pharmaceutical: Ping An Securities Co., Ltd.'s verification opinion on Zhejiang Jingxin Pharmaceutical Co., Ltd.'s use of some idle funds raised to temporarily supplement working capital.
Zhejiang Jingxin Pharmaceutical: Summary of Half-Year Report in 2024.
Zhejiang Jingxin Pharmaceutical: Announcement on the Temporary Supplement of Working Capital with Some Unused Raised Funds
Zhejiang Jingxin Pharmaceutical: Announcement regarding the return of raised funds.
Zhejiang Jingxin Pharmaceutical: Announcement regarding the release of pledged shares by major shareholders.
Zhejiang Jingxin Pharmaceutical: Announcement Regarding Enrofloxacin Active Pharmaceutical Ingredient, a wholly-owned subsidiary, obtaining the European CEP certificate.
Zhejiang Jingxin Pharmaceutical: 2023 Annual Equity Distribution Implementation Notice
